What is Piqray® (alpelisib)?
Written by: Editorial Team | Last reviewed: July 2019.
- Piqray. Cancer.org. May 30, 2019. Available at: https://www.breastcancer.org/treatment/targeted_therapies/piqray Accessed July 25, 2019.
- Tumor Characteristics: Hormone Receptor Status. Susan G. Komen Breast Cancer Foundation. January 31, 2019. Available at: https://ww5.komen.org/BreastCancer/TumorCharacteristics.html#her2 Accessed July, 12, 2019.
- FDA Approves First PI3K Inhibitor for Breast Cancer. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-pi3k-inhibitor-breast-cancer. Published May 24, 2019. Accessed July 25, 2019.
- Prescribing Information. Piqray. Novartis Pharmaceuticals Corporation. May 2019. Available at: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/piqray.pdf Accessed July 25, 2019.
- Piqray. DailyMed. US National Library of Medicine. May 24, 2019. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20b4e18-7a4b-4500-a08f-06c6dab0ee5b Accessed July 25, 2019.